Human Recombinant Galectin 7 (from E. coli)

Supplier: BioVision
AB62616-10
10006-912EA 131.16 USD
10006-912
Human Recombinant Galectin 7 (from E. coli)
Proteins and Peptides
>98% Pure active Recombinant human Galectin-7.

Measured by its ability to agglutinate human red blood cells. The ED₅₀ for the effect is typically 1-7 µg/ml.

Galectin-7 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of β-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds β-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin-7 is a 15.4 kDa protein consisting of 136 amino acid residues
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR